Short Interest in Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Grows By 700.0%

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 800 shares, an increase of 700.0% from the November 30th total of 100 shares. Based on an average trading volume of 200 shares, the short-interest ratio is currently 4.0 days.

Santhera Pharmaceuticals Price Performance

Shares of SPHDF remained flat at $9.42 during mid-day trading on Thursday. The business has a 50-day moving average of $10.92 and a 200 day moving average of $11.43. Santhera Pharmaceuticals has a 12 month low of $9.42 and a 12 month high of $9.42.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).